Keywords: asco, study, supports, first-line, taxol, phase, iii

ASCO STUDY SUPPORTS FIRST-LINE TAXOL

Article | 31 May 1993

Print This

A Phase III trial of Bristol-Myers Squibb's Taxol (paclitaxel) in advanced ovarian cancer patients looks set to change the way ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in